Wonhwa Lee Selected Research

Neoplasms (Cancer)

1/2023	Uniform Gold Nanostructure Formation via Weakly Adsorbed Gold Films and Thermal Annealing for Reliable Localized Surface Plasmon Resonance-Based Detection of DNase-I.
2/2021	Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
4/2016	Inhibitory effects of three diketopiperazines from marine-derived bacteria on endothelial protein C receptor shedding in human endothelial cells and mice.
4/2015	Anti-inflammatory effects of hyperoside in human endothelial cells and in mice.
5/2013	Barrier protective effects of rosmarinic acid on HMGB1-induced inflammatory responses in vitro and in vivo.
2/2013	Anti-inflammatory effects of oleanolic acid on LPS-induced inflammation in vitro and in vivo.
7/2012	Anticoagulant activities of oleanolic acid via inhibition of tissue factor expressions.
6/2012	Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
5/2012	Anti-inflammatory activities of oleanolic acid on HMGB1 activated HUVECs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wonhwa Lee Research Topics

Disease

40	Sepsis (Septicemia) 02/2022 - 02/2013
16	Inflammation (Inflammations) 02/2022 - 05/2012
13	Lung Injury 04/2021 - 08/2015
9	Neoplasms (Cancer) 01/2023 - 05/2012
9	COVID-19 01/2023 - 01/2020
6	Cytokine Release Syndrome 01/2022 - 01/2020
6	Septic Shock (Toxic Shock Syndrome) 01/2022 - 02/2013
5	Thrombosis (Thrombus) 05/2022 - 01/2015
5	Pneumonia (Pneumonitis) 01/2022 - 01/2019
4	Infections 10/2021 - 05/2013
4	cyclopia sequence 12/2015 - 08/2015
4	Pain (Aches) 12/2015 - 08/2015
3	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2022
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2021 - 11/2020
2	Atrophy 01/2024 - 10/2023
2	Multiple Organ Failure (MODS) 01/2022 - 01/2021
2	Pulmonary Edema 10/2020 - 02/2020
2	Diabetes Mellitus 06/2020 - 03/2016
2	Liver Failure 02/2018 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2015 - 10/2014
1	Sarcopenia 01/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Blindness (Hysterical Blindness) 01/2021
1	Macular Degeneration (Age-Related Maculopathy) 01/2021

Drug/Important Bio-Agent (IBA)

26	HMGB1 Protein (HMG1)IBA 02/2022 - 05/2012
12	CytokinesIBA 01/2024 - 05/2012
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2015
8	Particulate MatterIBA 04/2021 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2014
6	Local Anti-Infective Agents (Antiseptics)IBA 01/2021 - 08/2015
6	LipopolysaccharidesIBA 05/2020 - 02/2013
4	AntioxidantsIBA 10/2019 - 06/2012
4	Nuclear Proteins (Protein, Nuclear)IBA 01/2016 - 01/2014
3	GinsenosidesIBA 10/2023 - 01/2019
3	Deoxyribonuclease I (Nickase)IBA 01/2023 - 12/2020
3	decursinIBA 08/2021 - 01/2019
3	alloinIBA 10/2019 - 01/2019
3	AnticoagulantsIBA 11/2017 - 07/2012
3	Exenatide (Byetta)FDA Link 03/2016 - 10/2014
3	Oleanolic AcidIBA 02/2013 - 05/2012
3	TriterpenesIBA 02/2013 - 05/2012
2	protopanaxatriolIBA 10/2023 - 01/2019
2	Factor Xa (Coagulation Factor Xa)IBA 05/2022 - 01/2015
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	Melanins (Melanin)IBA 10/2021 - 12/2020
2	CholesterolIBA 06/2021 - 01/2020
2	Air Pollutants (Pollutants, Air)IBA 04/2021 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2021 - 06/2020
2	Peroxidase (Myeloperoxidase)IBA 10/2020 - 02/2020
2	Neutralizing AntibodiesIBA 01/2020 - 10/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 07/2014
2	Sirtuin 1IBA 01/2019 - 01/2018
2	zingeroneIBA 02/2018 - 07/2017
2	Glucagon-Like Peptide-1 ReceptorIBA 03/2016 - 04/2015
2	apigenin-6,8-di-C-glycopyranosideIBA 12/2015 - 08/2015
2	scolymosideIBA 12/2015 - 08/2015
2	Endothelial Protein C ReceptorIBA 04/2015 - 07/2014
2	activated protein C receptorIBA 04/2015 - 07/2014
2	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2014 - 03/2013
1	PowdersIBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	Transcription Factors (Transcription Factor)IBA 01/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023
1	Steroid Receptors (Steroid Receptor)IBA 10/2023
1	EndonucleasesIBA 01/2023
1	sparstolonin BIBA 05/2022
1	GlycosidesIBA 02/2022
1	Therapeutic UsesIBA 02/2022
1	IridoidsIBA 02/2022
1	cornusideIBA 02/2022
1	4,4'-dinitro-2,2'-stilbenedisulfonic acid (DNDS)IBA 01/2022
1	NanodiamondsIBA 01/2022
1	25-hydroxycholesterolIBA 06/2021
1	InflammasomesIBA 06/2021
1	didodecyldimethylammoniumIBA 06/2021
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 02/2021
1	Docetaxel (Taxotere)FDA Link 02/2021
1	ZeinIBA 02/2021
1	CY5.5 cyanine dyeIBA 02/2021
1	polydopamineIBA 01/2021
1	HCEIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	Toll-Like Receptor 2IBA 10/2020
1	TOR Serine-Threonine KinasesIBA 10/2020
1	cardamoninIBA 10/2020
1	Autophagy-Related ProteinsIBA 10/2020
1	Beclin-1IBA 10/2020
1	MB Form Creatine KinaseIBA 06/2020
1	biapenem (L 627)IBA 02/2020

Therapy/Procedure

11	Punctures 01/2022 - 02/2013
11	Ligation 01/2022 - 02/2013
9	Therapeutics 01/2022 - 02/2013
4	Traditional Medicine (Folk Remedies) 12/2015 - 08/2015
2	Nanospheres 10/2021 - 12/2020
1	Oral Administration 01/2024
1	Intravenous Injections 01/2022